Twenty‐five years of prescription opioid use in Australia: a whole‐of‐population analysis using pharmaceutical claims

Por Karanges, Emily A., Blanch, Bianca, Buckley, Nicholas A., Pearson, Sallie‐Anne
Publicado no Br J Clin Pharmacol (2016)

The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers

Por Mellish, Leigh, Karanges, Emily A., Litchfield, Melisa J., Schaffer, Andrea L., Blanch, Bianca, Daniels, Benjamin J., Segrave, Alicia, Pearson, Sallie-Anne
Publicado no BMC Res Notes (2015)

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study

Por Brett, Jonathan, Daniels, Benjamin, Karanges, Emily A., Buckley, Nicholas A., Schneider, Carl, Nassir, Atheer, McLachlan, Andrew J., Pearson, Sallie‐Anne
Publicado no Br J Clin Pharmacol (2017)

Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of “paradoxical” antidepressant respons...

Por Karanges, Emily A., Kashem, Mohammed A., Sarker, Ranjana, Ahmed, Eakhlas U., Ahmed, Selina, Van Nieuwenhuijzen, Petra S., Kemp, Andrew H., McGregor, Iain S.
Publicado em 2013

Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion

Por Motbey, Craig P., Karanges, Emily, Li, Kong M., Wilkinson, Shane, Winstock, Adam R., Ramsay, John, Hicks, Callum, Kendig, Michael D., Wyatt, Naomi, Callaghan, Paul D., McGregor, Iain S.
Publicado em 2012